Business Context and Reporting Period
This Form 8-K reports on the results of the 2020 Annual Meeting of Stockholders held by Capricor Therapeutics, Inc. on June 5, 2020. The meeting was conducted at the company's principal executive offices in Beverly Hills, California.
Key Financial Metrics
This filing is a current report regarding corporate governance and stockholder votes. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes and Voting Results
Stockholders representing 7,778,818 shares (of 12,464,006 entitled to vote) participated in the meeting. The following proposals were approved:
- Director Elections: All six nominees (Frank Litvack, Linda Marbán, David B. Musket, George W. Dunbar, Jr., Louis Manzo, and Earl M. Collier, Jr.) were elected to the Board of Directors.
- Auditor Ratification: The appointment of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020, was ratified.
- Equity Incentive Plan: The Capricor Therapeutics 2020 Equity Incentive Plan was adopted.
- Executive Compensation: Named executive officer compensation was approved via a non-binding advisory vote.
- Compensation Vote Frequency: Stockholders voted for a "1 Year" frequency for future non-binding advisory votes on executive compensation.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting results.
Investor Verification Checklist
- Verify the definitive proxy statement filed on April 17, 2020, for detailed descriptions of the proposals and director biographies.
- Confirm the total number of shares outstanding and the specific voting thresholds required for future corporate actions.
- Review the terms of the newly adopted 2020 Equity Incentive Plan to understand potential dilution impacts.
- Check subsequent filings for the company's financial performance, as this 8-K contains no financial data.